News Releases

July 14, 2021 at 8:00 AM EDT

Summary Toggle OptimizeRx Announces Agreement with a Top Pharmaceutical Manufacturer to Use its Evidence-Based Physician Engagement to Solve Lapse in Medical Coverage Barrier for Patients

OptimizeRx’s AI-driven platform leverages real-world evidence (RWE) to support doctors in their efforts to maintain patient treatment plans ROCHESTER, Mich. , July 14, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life

PDF Version
June 15, 2021 at 8:00 AM EDT

Summary Toggle OptimizeRx Aligned With Pharma Across Fast Growing Specialty Therapeutic Areas

Continued focus on building and closing pipeline of enterprise solutions across oncology, cardiology and immunology ROCHESTER, Mich. , June 15, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies,

PDF Version
June 1, 2021 at 8:00 AM EDT

Summary Toggle OptimizeRx Named to LD Micro’s “Hall of Fame” As One of the Top 50 Performing Companies

ROCHESTER, Mich. , June 01, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced today that Will Febbo , OptimizeRx’s CEO, will participate in the LD Micro Virtual

PDF Version
May 25, 2021 at 8:00 AM EDT

Summary Toggle OptimizeRx to Participate in the William Blair 41st Annual Growth Stock Conference

ROCHESTER, Mich. , May 25, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced today that Will Febbo , OptimizeRx’s, CEO will participate in a fireside chat at the

PDF Version
May 11, 2021 at 8:00 AM EDT

Summary Toggle OptimizeRx to Present at RBC Capital Markets Global Virtual Healthcare Conference on May 19, 2021

ROCHESTER, Mich. , May 11, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will participate in RBC Capital Markets Global Healthcare Virtual Conference .

PDF Version
May 6, 2021 at 4:01 PM EDT

Summary Toggle OptimizeRx Reports First Quarter 2021 Financial Results, Revenue Up 48% on Rising Enterprise Adoption of Digital Health

Revenue Up 48% to $11.2 million , closing on 33 enterprise contracts Expanded recurring revenue stream, reaching new base of customers Cash flow positive from operations of $1.7 million ROCHESTER, Mich. , May 06, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading

PDF Version
April 28, 2021 at 8:00 AM EDT

Summary Toggle OptimizeRx Sets First Quarter 2021 Conference Call for Thursday, May 6, 2021 at 4:30 p.m. ET

ROCHESTER, Mich. , April 28, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will hold a conference call on Thursday, May 6, 2021 , at 4:30 p.m.

PDF Version
April 27, 2021 at 7:51 AM EDT

Summary Toggle OptimizeRx Expands Omni-channel Platform Reach at Point-Of-Care

Several New Partnerships Expand Reach to Over 50% of Oncologists in the U.S. and Unlock Novel Touchpoints for Life Sciences to Engage Physicians ROCHESTER, Mich. , April 27, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science

PDF Version
April 13, 2021 at 7:51 AM EDT

Summary Toggle OptimizeRx Named to Financial Times ―The Americas’ Fastest-Growing Companies List for the Second Consecutive Year

Ranked #277, highlighting the growth potential and convergence between technology and healthcare ROCHESTER, Mich. , April 13, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians, and patients, has received

PDF Version
March 16, 2021 at 7:30 AM EDT

Summary Toggle OptimizeRx Recurring Revenue Grows as it Secures 19 New Enterprise-Level Engagements in Q1 2021

ROCHESTER, Mich. , March 16, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has secured 19 new enterprise-level deals for 2021 that provide access to the company’s full suite of solutions

PDF Version